Drug craving is a key feature of addiction, driven by complex neural mechanisms involving reward and memory circuits. The mesolimbic dopamine pathway, particularly the nucleus accumbens, plays a central role in craving by reinforcing substance-related cues. The prefrontal cortex, responsible for decision-making and impulse control, often exhibits impaired functioning, making it difficult for individuals to resist urges. Additionally, the amygdala and hippocampus contribute by linking emotional and contextual triggers to past substance use experiences. Neuroimaging studies have revealed heightened activity in these brain regions during craving episodes, highlighting potential targets for interventions like transcranial magnetic stimulation (TMS) and pharmacotherapy to reduce craving intensity.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States